Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Top Cited Papers
- 1 June 2002
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 359 (9323), 2072-2077
- https://doi.org/10.1016/s0140-6736(02)08905-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- The Diabetes Prevention Program: headline resultsBritish Journal of Diabetes, 2001
- The STOP-NIDDM Trial: An international study on the efficacy of an α-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening dataDiabetes Care, 1998
- The Effect of Acarbose on Insulin Sensitivity in Subjects With Impaired Glucose ToleranceDiabetes Care, 1996
- The Efficacy of Acarbose in the Treatment of Patients with Non–Insulin-Dependent Diabetes Mellitus: A Multicenter, Controlled Clinical TrialAnnals of Internal Medicine, 1994
- Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1994
- Cardiovascular disease risk factors as predictors of Type 2 (non-insulin-dependent) diabetes mellitus in elderly subjectsDiabetologia, 1993
- Glucose ToxicityDiabetes Care, 1990
- The Natural History of Impaired Glucose Tolerance in the Pima IndiansNew England Journal of Medicine, 1988
- A rapid method for the determination of glycosylated hemoglobins using high pressure liquid chromatographyMetabolism, 1978